SPECIFIC PHARMA A/S
Core data
Name | SPECIFIC PHARMA A/S |
Address | Borgmester Christiansens Gade 40, 2450, København SV |
Founded | Sep 15, 2010 |
| 40 / 37 | |
Locations (P-units) | 1View locations |
Website | https://specificpharma.com/ |
VAT registered | |
Branch | Engroshandel med medicinalvarer og sygeplejeartikler (464610) |
Name | SPECIFIC PHARMA A/S |
Address | Borgmester Christiansens Gade 40, 2450, København SV |
Founded | Sep 15, 2010 |
| 40 / 37 |
Locations (P-units) | 1View locations |
Website | https://specificpharma.com/ |
VAT registered | |
Branch | Engroshandel med medicinalvarer og sygeplejeartikler (464610) |
Keep track of SPECIFIC PHARMA A/S
Description
Specific Pharma is a European market leader in unlicensed medicines and medicines for special purposes, including clinical trials and drug shortages. It helps patients with unmet medical needs by providing the right medicine in a timely manner.
Specific Pharma helps healthcare professionals and patients gain access to unavailable human and veterinary medicines. It sources and imports medicines through a network of health authorities, healthcare professionals, suppliers, and others, including for named-patient, compassionate-use, and special-permit procedures.
Company's own description on virk.dk
Selskabets hovedaktivitet består i sourcing og distribution af speciallægemidler til hospitaler, apoteker og internationale samarbejdspartnere samt håndtering af kliniske forsyninger (CTSM).
Products & services
Access to unlicensed medicines · Access to medicines for clinical trials · Access to medicines during drug shortages · Sourcing of human medicines · Sourcing of veterinary medicines · Import of medicines · Named-patient, compassionate-use, and special-permit procedures
Industries
Healthcare · Pharmaceuticals
Customer types
Healthcare professionals · Patients · Pharmacies
Analysis by AI ✨
Specific Pharma recorded revenue of DKK 157.8 million and a profit after tax of DKK 15.2 million in the 2025/26 financial year; the previous year, revenue was DKK 219.3 million and profit after tax was DKK 29.2 million. The annual report describes lower revenue and earnings in 2025 than in 2024, when revenue was affected by exceptional non-recurring activities, including larger one-off deliveries and temporary supply disruptions across Europe.
In August 2026, Specific Pharma had 40 employees and 37 full-time equivalents (FTE).
The company’s registered direct owner is NOMECO A/S, which is owned by PHOENIX DANISH HOLDING A/S. PHOENIX DANISH HOLDING A/S is owned by PHOENIX International Holdings GmbH in Germany.
AI-generated texts are based on registered information, which may be delayed or incomplete. Errors may occur.
Financials
| Reporting period | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 157,797,000 | ||||||||
| Gross profit | 38,182,000 | ||||||||
| Operating profit | 15,191,000 | ||||||||
| Profit before tax | 19,485,000 | ||||||||
| Net income | 15,192,000 | ||||||||
| Total assets | 115,179,000 | ||||||||
| Equity | 98,645,000 | ||||||||
| Avg. employees | 37 | ||||||||
2018–2026 Unlock financial history | |||||||||
Datapublica Risk Score
What goes into the assessment
Financials
Equity ratio, profitability, and liquidity
Accounts and history
Late filings and previous financial distress
Owners and management
Past bankruptcies and owners’ other companies
Company and connections
Age, industry, and shared addresses or contact details
Standard: Score and risk bandPro: Also a detailed explanation of the factors
Contact
From specificpharma.com
| Contact | Phone | |
|---|---|---|
| OUR FOCUS | +45 3645 ****Show full | — |
People
| Person | Roles | Titles |
|---|---|---|
| Henrik Kaastrup | Roles Board | TitlesBESTYRELSESMEDLEM |
| Kasper Casparij Yde | Roles Board | TitlesBESTYRELSESMEDLEM |
| Ken Rasmussen | Roles Board | TitlesBESTYRELSESMEDLEM |
| Kristine Sakstrup Haag | Roles Board | TitlesFORMAND |
| Søren Vesti Esbensen | Roles Board | TitlesSUPPLEANT |
| Uffe Kåre Jensen | Roles Management | TitlesADM. DIR. |
Auditor
| Audit firm | Auditor | Role | From |
|---|---|---|---|
| Forvis Mazars Statsautoriseret Revisionspartnerselskab | AuditorKarsten Vedel | Rolestatsaut. revisor | FromJun 26, 2026 |
Legal owners
| Owner | Ownership | Voting rights | From |
|---|---|---|---|
| Ownership100 % | Voting rights100 % | FromSep 15, 2014 |
Ultimate owners
| Name | Ownership through | Calculated ownership |
|---|---|---|
| 🇩🇪PHOENIX International Holdings GmbH | Ownership through | 100 % |